KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Raw Materials (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Raw Materials for 17 consecutive years, with $1.6 billion as the latest value for Q4 2025.

  • Quarterly Raw Materials fell 2.78% to $1.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 billion through Dec 2025, down 2.78% year-over-year, with the annual reading at $1.6 billion for FY2025, 2.78% down from the prior year.
  • Raw Materials hit $1.6 billion in Q4 2025 for Abbott Laboratories, down from $1.6 billion in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $2.0 billion in Q2 2023 to a low of $1.4 billion in Q4 2021.
  • Historically, Raw Materials has averaged $1.7 billion across 5 years, with a median of $1.7 billion in 2024.
  • Biggest five-year swings in Raw Materials: grew 29.17% in 2021 and later dropped 10.73% in 2025.
  • Year by year, Raw Materials stood at $1.4 billion in 2021, then increased by 22.14% to $1.7 billion in 2022, then increased by 7.64% to $1.8 billion in 2023, then decreased by 8.97% to $1.7 billion in 2024, then fell by 2.78% to $1.6 billion in 2025.
  • Business Quant data shows Raw Materials for ABT at $1.6 billion in Q4 2025, $1.6 billion in Q3 2025, and $1.7 billion in Q2 2025.